FDA Approves Cervical Cancer Vaccine - CME Teaching Brief - MedPage Today
OCKVILLE, Md. June 8 — The FDA today approved Gardasil (quadrivalent human papillomavirus [Types 6, 11, 16, 18] recombinant vaccine) for prevention of cervical cancer and for prevention of cervical, vulvar and vaginal pre-cancers caused by HPV types 16 and 18.
The agency said the vaccine, made by Merck, was approved for immunization of girls and women ages nine to 26. The vaccine was not approved for immunization of boys, however, a blow to the cancer prevention community that had campaigned for approval in both boys and girls.
Posted by gruwell at June 12, 2006 10:07 AM | TrackBack